Associated Papers
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial.
Hoyer K et al.
Ebiomedicine, 2021
33862582 (PubMed )
Supplement: mmc3.xlsx › S5
The rate of germline mutations and large deletions of SMAD4 and BMPR1A in juvenile polyposis.
Calva-Cerqueira D et al.
Clinical Genetics, 2009
Development of a denaturing high-performance liquid chromatography screening method for SMAD4 in juvenile polyposis syndrome.
Hatch SL et al.
Annals of Clinical Biochemistry, 2007
Aryl hydrocarbon receptor-interacting protein and acromegaly.
Aaltonen LA
Hormone Research, 2007
Genetic conditions associated with intestinal juvenile polyps.
Merg A et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 2004
The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations.
Howe JR et al.
Journal of Medical Genetics, 2004
Molecular dimensions of gastrointestinal tumors: some thoughts for digestion.
Cohen MM
American Journal of Medical Genetics. Part A, 2003
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes.
Zhou XP et al.
American Journal of Human Genetics, 2001
Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.
Howe JR et al.
Nature Genetics, 2001
Select a paper to view details